HR 1552 · 114th Congress 2015–2017, ended

Preservation of Antibiotics for Medical Treatment Act of 2015

Latest action · Mar 27, 2015 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 23, 2015
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Preservation of Antibiotics for Medical Treatment Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to require an applicant for approval of a new animal drug that is a medically important antimicrobial to demonstrate that there is a reasonable certainty of no harm to human health from antimicrobial resistance attributable to the nontherapeutic use of the drug.

Medically important antimicrobials are drugs intended for use in food-producing animals that contain: (1) specified antibiotics, or (2) certain drugs on the World Health Organization’s list of critically important antimicrobials.

Two years after enactment of this Act, the Food and Drug Administration (FDA) must withdraw approval of a drug's nontherapeutic use in food-producing animals unless the FDA makes a determination that, based on the application holder's demonstration or an FDA risk analysis, there is a reasonable certainty of no harm to human health from antimicrobial resistance attributable to nontherapeutic use.

The FDA must rescind an exemption for investigational use of, or approval of a new drug application for, a medically important antimicrobial for its nontherapeutic use in food-producing animals two years after the exemption is granted or the application for approval is submitted unless there is a reasonable certainty of no harm to human health from antimicrobial resistance attributable to nontherapeutic use.

A medically important antimicrobial cannot be administered (including through animal feed) to a food-producing animal for disease control unless there is a significant risk that a disease or infection present on the premises will be transmitted to the animal.

Cosponsors 77

Members who signed on, in the order they did. Signatures ran from Mar 23, 2015 to Nov 29, 2016; 21 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-CAAdam B. SchiffOriginalMar 23, 2015
D-CAAlan S. LowenthalOriginalMar 23, 2015
D-CAAnna G. EshooOriginalMar 23, 2015
D-NYCarolyn B. MaloneyOriginalMar 23, 2015
D-NYCharles B. RangelOriginalMar 23, 2015
D-MEChellie PingreeOriginalMar 23, 2015
D-MDDonna F. EdwardsOriginalMar 23, 2015
D-OREarl BlumenauerOriginalMar 23, 2015
D-VAGerald E. ConnollyOriginalMar 23, 2015
D-WIGwen MooreOriginalMar 23, 2015
D-CAJackie SpeierOriginalMar 23, 2015
D-ILJanice D. SchakowskyOriginalMar 23, 2015
D-PAMatt CartwrightOriginalMar 23, 2015
D-MANiki TsongasOriginalMar 23, 2015
D-VTPeter WelchOriginalMar 23, 2015
D-AZRaúl M. GrijalvaOriginalMar 23, 2015
D-CTRosa L. DeLauroOriginalMar 23, 2015
D-CASam FarrOriginalMar 23, 2015
D-MISander M. LevinOriginalMar 23, 2015
D-FLTheodore E. DeutchOriginalMar 23, 2015
D-NYYvette D. ClarkeOriginalMar 23, 2015
D-HITulsi GabbardMar 26, 2015
D-NCDavid E. PriceApr 16, 2015
D-RIJames R. LangevinApr 16, 2015
D-CAZoe LofgrenApr 16, 2015
D-CTJames A. HimesApr 27, 2015
D-NYPaul TonkoMay 5, 2015
D-CAGrace F. NapolitanoMay 13, 2015
D-CAJared HuffmanMay 13, 2015
D-NHAnn M. KusterMay 19, 2015
D-MNKeith EllisonMay 19, 2015
D-KYJohn A. YarmuthJun 3, 2015
D-OHTim RyanJun 3, 2015
D-CTJohn B. LarsonJun 4, 2015
D-CODiana DeGetteJun 9, 2015
D-WARick LarsenJun 9, 2015
D-ILDaniel LipinskiJul 7, 2015
D-NYGrace MengJul 7, 2015
D-CAMark DeSaulnierJul 9, 2015
D-CABarbara LeeJul 28, 2015
D-DCEleanor Holmes NortonSep 8, 2015
D-CAMaxine WatersSep 8, 2015
D-ORPeter A. DeFazioSep 8, 2015
D-CATed LieuSep 16, 2015
D-FLAlan GraysonNov 4, 2015
D-FLAlcee L. HastingsNov 4, 2015
D-MNBetty McCollumNov 4, 2015
D-NJBonnie Watson ColemanNov 4, 2015
D-MDChris Van HollenNov 4, 2015
D-CADoris O. MatsuiNov 4, 2015
D-ILMike QuigleyNov 4, 2015
D-NVDina TitusNov 5, 2015
D-WAJim McDermottNov 16, 2015
D-CAJuan VargasNov 16, 2015
D-CAPete AguilarNov 19, 2015
D-CAMichael M. HondaJan 5, 2016
D-VADonald S. Beyer, Jr.Jan 7, 2016
D-NYJose E. SerranoJan 7, 2016
D-OHMarcy KapturJan 7, 2016
D-MAWilliam R. KeatingJan 8, 2016
D-NYSteve IsraelFeb 2, 2016
D-RIDavid N. CicillineFeb 10, 2016
D-MASeth MoultonFeb 25, 2016
D-PAChaka FattahApr 13, 2016
D-NJDonald M. Payne, Jr.Apr 13, 2016
D-WAAdam SmithMay 3, 2016
D-MAJames P. McGovernJul 14, 2016
D-TNSteve CohenJul 14, 2016
D-NYHakeem S. JeffriesJul 21, 2016
D-CAMark TakanoJul 21, 2016
D-CALinda T. SánchezSep 6, 2016
D-ILLuis V. GutierrezSep 6, 2016
D-ILBobby L. RushSep 20, 2016
D-NJDonald NorcrossSep 20, 2016
D-TXLloyd DoggettSep 20, 2016
D-TXMarc A. VeaseySep 28, 2016
D-CTElizabeth H. EstyNov 29, 2016

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 23, 2015
Health Subcommittee
Referred Mar 27, 2015

Actions 4

Everything that happened, newest first.

  1. Mar 27, 2015Referred to the Subcommittee on Health.
  2. Mar 24, 2015Sponsor introductory remarks on measure. (CR E400-401)
  3. Mar 23, 2015Introduced in House
  4. Mar 23, 2015Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
ExtensionsDebate and remarks E394, E400Louise McIntosh Slaughter D-NYMar 24, 2015

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Clauses 1, 3, and 18 of Section 8 of Article I of the Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 161, no. 48, March 23, 2015, page H1849.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 1587Preservation of Antibiotics for Medical Treatment Act of 2017Reintroduced BillMay 8, 2018

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases.
Short Titles as Introduced
Preservation of Antibiotics for Medical Treatment Act of 2015

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 23, 2015Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.